Based on current scientific evidence, there is no risk of a blood clot caused by the COVID-19 vaccine manufactured by AstraZeneca.
European Medicines Agency said that a full investigation is ongoing into reports of blood clots in people, including one case in Denmark where an older person died. EMA’s safety committee, the Pharmacovigilance Risk Assessment Committee (PRAC), is reviewing all cases of blood clots. The agency also stated that the blood clot is not listed as a side effect of this vaccine.
Further, the blood clot reports received so far are not greater than the normal number that would have occurred in the vaccinated population.
AstraZeneca has asserted that there is no evidence of clot-formation in vaccine recipients, and the vaccine has undergone more than 60 quality tests that meet stringent criteria.
Even though there have been incidents of blood clots in people who received the AstraZeneca shots, a direct link to the vaccine being responsible for the clot formation has not been determined. A further study analysis that is currently underway is expected to review the clotting incidents and determine the reason behind them.
The COVID-19 pandemic has given rise to a lot of potentially dangerous misinformation. For reliable advice on COVID-19 including symptoms, prevention and available treatment, please refer to the World Health Organisation or your national healthcare authority.